Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Merkel cell polyomavirus Stories

2014-01-27 08:27:54

Trial to evaluate ID-G100 in patients with Merkel cell carcinoma SEATTLE and SOUTH SAN FRANCISCO, Calif., Jan. 27, 2014 /PRNewswire/ -- Immune Design, a clinical-stage biotechnology company focused on the development of novel immune-based therapies for cancer and other chronic conditions, today announced treatment of the first patient in a Phase 1 clinical trial of ID-G100 in patients with Merkel cell carcinoma (MCC). (Logo: http://photos.prnewswire.com/prnh/20130926/SF87058LOGO)...

2012-10-23 07:28:13

SAN DIEGO, Oct. 23, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapies to treat solid tumor cancers, announced positive preliminary results from a Phase II multicenter trial investigating the use of ImmunoPulse in Merkel cell carcinoma (MCC) patients at the 27th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2012). The data suggest that ImmunoPulse, which locally delivers...

2012-07-11 02:25:02

SAN DIEGO, July 11, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announces it has established the University of California San Francisco (UCSF) as the second enrolling site for its Phase II Merkel cell carcinoma clinical trial (OMS-I110). UCSF investigators are actively recruiting patients for this clinical trial. OMS-I110 was initiated at the University of...

2012-05-09 21:36:44

Four years after they discovered the viral roots of a rare skin cancer, researchers at the University of Pittsburgh Cancer Institute (UPCI) and the School of Medicine have now identified a molecule activated by this virus that, in animal studies, could be targeted to selectively kill the tumor cells. The treatment will soon be tested in patients. Merkel cell carcinoma (MCC), a skin cancer that is more common among seniors and those with weakened immune systems, could not be readily...

2012-03-19 02:24:32

SAN DIEGO, March 19, 2012 /PRNewswire/ -- OncoSec Medical Incorporated. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that Dr. Paul Nghiem, Co-Principal Investigator for OncoSec's Phase II Merkel cell carcinoma study has been invited to chair a special forum session at the 70th Annual American Academy of Dermatology meeting in San Diego, CA, titled, "Merkel Cell Carcinoma:...

2012-03-07 05:01:00

SAN DIEGO, March 7, 2012 /PRNewswire/ -- OncoSec Medical Incorporated (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that Dr. Shailender Bhatia, Principal Investigator for the company's Phase II Merkel cell carcinoma clinical trial, was featured in a local Seattle news outlet, The Journal Newspaper. (Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO) The article, titled...

2012-02-13 05:01:00

SAN DIEGO, Feb. 13, 2012 /PRNewswire/ -- OncoSec Medical Incorporated (OTCBB: ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that physicians at the University of Washington and Seattle Cancer Care Alliance in conjunction with the Fred Hutchinson Cancer Center, have treated several patients in an open-label Phase II clinical trial evaluating OncoSec's OMS ElectroImmunotherapy for the...

2012-01-18 05:01:00

SAN DIEGO, Jan. 18, 2012 /PRNewswire/ -- OncoSec Medical Incorporated (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, presented its corporate strategy for 2012 and reported on progress since launch of the company last year at the Biotech Showcase and OneMedForum conferences held January 9-13 in San Francisco, CA. (Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO) "Despite a financially...

2009-09-24 07:17:30

The Merkel cell polyomavirus (MCPyV) is the only human polyomavirus known to be associated with a rare skin cancer, known as Merkel cell carcinoma, according to a new study published online September 23 in the Journal of the National Cancer Institute. The majority of patients with Merkel cell carcinoma carry MCPyV, but little is known about the polyomavirus' prevalence in the general population and the association between circulating antibodies against MCPyV and the rare skin cancer. Denise...

2009-07-30 12:30:43

A virus discovered last year in a rare form of skin cancer has also been found in people with the second most common form of skin cancer among Americans, according to researchers at the Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.The researchers examined tissue samples from 58 people with squamous cell carcinoma (SCC), a highly curable form of skin cancer that is expected to affect more than 200,000 Americans this year.They...


Latest Merkel cell polyomavirus Reference Libraries

45_c8d4395f53eb6d3d4b08458e135e5ef0
2011-02-23 17:31:48

Polyomavirus is the sole genus of viruses within the family Polyomaviridae. Ludwik Gross discovered the first polyomavirus, Murine polyomavirus, in 1963. Many polyomaviruses infect birds and mammals and have been extensively studied as tumor viruses in humans and animals. Polyomaviruses are DNA-based, small, and icosahedral in shape. They can potentially cause tumors and often persist as latent infections in a host without causing disease. There are three major clades or...

45_16476fe85b6c94ca2cddefe0d4dea632
2011-02-17 16:45:25

Merkel cell polyomavirus (MCV or MCPyV), first discovered in January 2008, is one of seven human tumor viruses. It is suspected to cause most of Merkel cell carcinoma which is a rare, aggressive form of skin cancer. Around 80% of Merkel cell carcinoma tumors are found to be infected with MCV. It is found in respiratory secretions suggesting that it may be transmitted by a respiratory route. Usually the tumors with MCV viruses go through at least two mutations that render the virus...

More Articles (2 articles) »